Novel applications of recombinant factor VIIa: The effect of the administration of recombinant activated factor VII (NovoSeven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: The prose study

Infusionstherapie und Transfusionsmedizin

Volumn 28, Issue 2, 2001, Pages 112-113

  Friederich, P W ^a   Geerdink, M G F ^a   Keller, T T ^a   Messelink, E J ^a   Henny, C P ^a   Levi, M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GLANZMANN DISEASE; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; MALE; PERIOPERATIVE PERIOD; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; VON WILLEBRAND DISEASE;

EID: 0035034561     PISSN: 14245485     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)